Literature DB >> 11191665

Treatment of systemic mast-cell disease with cladribine.

A Tefferi, C Y Li, J H Butterfield, H C Hoagland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11191665     DOI： 10.1056/NEJM200101253440415

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

Review 1.  Mastocytosis and disorders of mast cell proliferation.

Authors:  Joanne K Simpson; Dean D Metcalfe
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  ["Smoldering systemic mastocytosis. "Successful therapy with cladribine].

Authors:  V Schleyer; S Meyer; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

3.  Advanced mast cell disease: an Italian Hematological Multicenter experience.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Morena Caira; Michela Rondoni; Maria Teresa Van Lint; Anna Candoni; Bernardino Allione; Chiara Cattaneo; Laura Marbello; Cecilia Caramatti; Enrico Maria Pogliani; Emilio Iannitto; Fiorina Giona; Felicetto Ferrara; Rosangela Invernizzi; Rosa Fanci; Monia Lunghi; Luana Fianchi; Grazia Sanpaolo; Pietro Maria Stefani; Alessandro Pulsoni; Giovanni Martinelli; Giuseppe Leone; Pellegrino Musto
Journal:  Int J Hematol       Date:  2008-11-26       Impact factor: 2.490

Review 4.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

Review 5.  Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors:  M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal:  Osteoporos Int       Date:  2016-02-18       Impact factor: 4.507

6.  Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial.

Authors:  D J DeAngelo; T I George; A Linder; C Langford; C Perkins; J Ma; P Westervelt; J D Merker; C Berube; S Coutre; M Liedtke; B Medeiros; D Sternberg; C Dutreix; P-A Ruffie; C Corless; T J Graubert; J Gotlib
Journal:  Leukemia       Date:  2017-07-24       Impact factor: 11.528

7.  International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.

Authors:  Jason Gotlib; Animesh Pardanani; Cem Akin; Andreas Reiter; Tracy George; Olivier Hermine; Hanneke Kluin-Nelemans; Karin Hartmann; Wolfgang R Sperr; Knut Brockow; Lawrence B Schwartz; Alberto Orfao; Daniel J Deangelo; Michel Arock; Karl Sotlar; Hans-Peter Horny; Dean D Metcalfe; Luis Escribano; Srdan Verstovsek; Ayalew Tefferi; Peter Valent
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

Review 8.  Contemporary challenges in mastocytosis.

Authors:  H David Pettigrew; Suzanne S Teuber; James S Kong; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 9.  Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.

Authors:  Siham Bibi; Melis Dilara Arslanhan; Florent Langenfeld; Sylvie Jeanningros; Sabine Cerny-Reiterer; Emir Hadzijusufovic; Luba Tchertanov; Richard Moriggl; Peter Valent; Michel Arock
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

10.  Regulation of normal and neoplastic human mast cell development in mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Trans Am Clin Climatol Assoc       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.